WebCisplatin plus gemcitabine is given to shrink bladder tumors and decrease symptoms from bladder cancer. It can be given either after surgery to eliminate microscopic cells, … WebGallbladder cancer is a highly aggressive malignancy with poor sensitivity to postoperative radiotherapy or chemotherapy; therefore, the development of individualized treatment strategies is paramount to improve patient outcomes. ... These results demonstrate that GEM+CIS treatment results in long-lasting suppression of large tumors and predict ...
Cisplatin (chemotherapy drug) - treatment and side effects
WebMay 14, 2024 · The BCAT trial and the PRODIGE-12/ACCORD-18 trial have failed to show any benefit with gemcitabine (Gem) or with the combinations of gemcitabine and oxaliplatin (GemOx) chemotherapy in patients with resected BTC when compared to an observation alone arm [13,14]. WebDec 5, 2013 · I did a quick search for a recent post exclusively on experiences with gem/cis chemotherapy and didn’t see one, so I’m starting this post in the hopes that it’ll be … cynthia padgett roanoke va
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung …
WebJan 19, 2024 · Surgical and other local treatments for cholangiocarcinoma and ampullary cancer; the epidemiology, pathology, classification, clinical presentation, and diagnosis of … WebJul 9, 2024 · Metastatic pancreatic ductal adenocarcinomas (PDACs) are now more effectively controlled using chemotherapy combinations such as FOLFIRINOX and gemcitabine plus nab-paclitaxel (NabP) regimens with a subset of patients who achieve a sustained tumor stabilization or response. The next challenge is to design maintenance … WebMay 31, 2024 · chemotherapy group and 238 in the standard-therapy group). At a median follow- up of 42.7 months, the 3-year recurrence-free survival was 85.3% in the induction biltmore area partnership